Panel: FDA Should OK Marijuana-Based Epilepsy Drug

A marijuana-derived epilepsy drug should be approved by the U.S. Food and Drug Administration, an advisory committee unanimously recommended on Thursday.

If approved in an expected FDA vote in June, Epidiolex would be the first plant-derived cannabidiol medicine for prescription use in the U.S., CNNreported.

The committee recommended that Epidiolex, an oral solution, be approved for treatment of severe, early-onset forms of epilepsy in a small number of patients.

More